Related references
Note: Only part of the references are listed.Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Samuel D. Banister et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan
Ruri Kikura-Hanajiri et al.
DRUG TESTING AND ANALYSIS (2014)
Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013
Heesun Chung et al.
FORENSIC TOXICOLOGY (2014)
Analysis of the prevalence and coexistence of synthetic cannabinoids in herbal high products in Poland
Dariusz Zuba et al.
FORENSIC TOXICOLOGY (2013)
New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products
Nahoko Uchiyama et al.
FORENSIC TOXICOLOGY (2013)
Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products
Nahoko Uchiyama et al.
FORENSIC TOXICOLOGY (2013)
Share Paper
